Study in Patients With COPD

A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01168310 ·Status: COMPLETED ·Phase: PHASE2

A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01053988 ·Status: COMPLETED ·Phase: PHASE3

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00685841 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

NCT00064415 ·Status: COMPLETED ·Phase: PHASE3

Enhancement of in-Vitro GC Function in Patients With COPD

NCT00241631 ·Status: COMPLETED ·Phase: PHASE2

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

NCT06154837 ·Status: RECRUITING ·Phase: PHASE1

Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00545311 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)

NCT01488019 ·Status: COMPLETED ·Phase: PHASE4

NVA237 BID Versus Placebo Twelve-week Efficacy Study

NCT01715298 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01437540 ·Status: COMPLETED ·Phase: PHASE3

Effect of NVA237 on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01154127 ·Status: COMPLETED ·Phase: PHASE3

CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD

NCT05097014 ·Status: COMPLETED ·Phase: PHASE4

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

NCT00403286 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of ICS/LABA vs. LAMA/LABA in Patients With Different COPD Phenotypes.

NCT05342558 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

NCT02815488 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD

NCT00064402 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01054885 ·Status: COMPLETED ·Phase: PHASE3

A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary Disease

NCT01033487 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations

NCT00116402 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

NCT00791518 ·Status: COMPLETED

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

NCT01049360 ·Status: COMPLETED ·Phase: PHASE2

Budesonide / Formoterol in Treatment of Exacerbations of COPD

NCT00239278 ·Status: COMPLETED ·Phase: PHASE2

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

NCT00742248 ·Status: COMPLETED ·Phase: PHASE2

Enhancement of Corticosteroid Efficacy in COPD

NCT02340520 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of CHF 5993 pMDI With and Without Spacer in COPD Patients

NCT02119234 ·Status: COMPLETED ·Phase: PHASE1